BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.
Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.
Latest Press Release
Buy-back of ordinary shares in BONESUPPORT HOLDING AB 15-18 June 2026 (week 25). The buy-back program is now completed and closed.
2026-06-22
Buy-back of ordinary shares in BONESUPPORT HOLDING AB 9-12 June 2026 (week 24)
2026-06-15
BONESUPPORT HOLDING AB initiates buy-back of ordinary shares for long-term incentive program
2026-06-08